Trials / Completed
CompletedNCT01712867
The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels
The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels in Hypertriglyceridemia Patients: A Double-blind, Randomized, Noninferiority Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 201 (actual)
- Sponsor
- Enzymotec · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to determine the efficacy of phytosterol esters of omega-3 (Vayarol) versus Omega-3 acids ethyl esters in reducing triglyceride levels in hypertriglyceridemia patients with fasting triglyceride levels ≥ 200 and \< 500 mg/dL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Omega-3 acid ethyl esters | 4 capsules/day for 12 weeks |
| OTHER | Phytosterol esters of omega-3 | 4 capsules/day for 12 weeks |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2014-11-01
- Completion
- 2014-12-01
- First posted
- 2012-10-24
- Last updated
- 2018-04-11
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01712867. Inclusion in this directory is not an endorsement.